Retained Biliary Plastic Stents: Clinical Presentation, Complications, and Management

Abstract

Background Biliary plastic stent (PS) mandates timely removal or replacement. The coronavirus disease 2019 (COVID-19) pandemic had affected the accessibility to medical therapy resulting in delay. We evaluated the burden of retained biliary PS, clinical profile, and impact of COVID-19 pandemic on stent retention.

Material and Method Endoscopy database records between November 2019 and April 2022 were reviewed retrospectively to identify patients who had undergone stent exchange or removal > 3 months, that is, retained stents. Demography, comorbidity, indication and outcomes of index endoscopic retrograde cholangiopancreatography, size and duration of indwelling biliary PS, clinical presentation, imaging findings, cholangiography findings, stent-related complications, and stone formation and endotherapy details were noted.

Results A total of 252 patients (100 [39.68%] males; median age 47 years [interquartile range [IQR] 32–56 years]) had common bile duct (CBD) stent retention. Median duration of retained CBD stent was 5 months (IQR = 4–6 months). Seventy (27.8%) were symptomatic with cholangitis (22, 8.7%), only jaundice (16, 6.3%), and only biliary abdominal pain (32, 12.7%). Sixty-one of 70 (87.1%) had abnormal imaging; 59/70 (84.3%) had new onset biliary stone or sludge (p ≤ 0.005). Stent retention > 6 months was significantly associated with stent fragmentation (0 vs. 20, p < 0.005) and choledocholithiasis (9 vs. 58, p < 0.005). Small caliber stent retention was more symptomatic (7 vs. 10 French [12/28 [42.85%] vs. 58/224 [25%], p = 0.049]). Univariate logistic regression analysis showed serum aspartate aminotransferase (AST), alkaline phosphatase levels, and CBD stent retention > 6 months were significantly associated with complications. On multivariate logistic regression analysis, serum AST > 2× upper limit normal (odds ratio [OR] = 5.487, 95% confidence interval [CI] = 3.1–9.9, p ≤ 0.005) and CBD stent retention > 6 months (OR = 8.6, CI = 3.1–23.92, p ≤ 0.005) were associated with complications. Out of 101 COVID-19 pandemic-attributed delay, 56/101 (55.44%) had symptomatic stent dysfunction. Endoscopic technical success rate was 97%, unsuccessful ones were due to large stones and impacted stents; with no mortality.

Conclusion CBD PS stent retention, although mostly asymptomatic, can result in significant morbidity like jaundice, cholangitis, stent migration, fragmentation, or impaction in one-fourth of patients. Use of 7 Fr stent, retention duration > 6 months, abnormal imaging findings, and AST > twice the upper limit were significantly associated with complications. Endoscopic management was successful in 97% of patients.

Keywords

biliary plastic stents - retained stent - choledocholithiasis - jaundice - cholangitis endoscopic retrograde cholangiopancreatography

^* Co-first authors

Publication History

Article published online:
22 April 2024

• References

• 1 Manes G, Paspatis G, Aabakken L. et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2019; 51 (05) 472-491
• 2 Bagul A, Pollard C, Dennison AR. A review of problems following insertion of biliary stents illustrated by an unusual complication. Ann R Coll Surg Engl 2010; 92 (04) W27–31
• 3 Odabasi M, Arslan C, Akbulut S. et al. Long-term effects of forgotten biliary stents: a case series and literature review. Int J Clin Exp Med 2014; 7 (08) 2045-2052
• 4 Jaleel R, Simon EG, Gupta P, Patnaik I, David D, Chowdhury SD. Retained biliary plastic stents - lest we forget. Trop Doct 2021; 51 (02) 177-180
• 5 Sohn SH, Park JH, Kim KH, Kim TN. Complications and management of forgotten long-term biliary stents. World J Gastroenterol 2017; 23 (04) 622-628
• 6 Duman AE, Yılmaz H, Hülagü S. Biliary stents are forgotten more frequently in elderly patients. Turk J Med Sci 2021; 51 (06) 3067-3072
• 7 Costa L, Bracco P, Vada S, Trossarelli L, Jacobson K. A chemical analysis of the clogging process of polymeric biliary endoprostheses. Biomaterials 2001; 22 (23) 3113-3119
• 8 Donelli G, Guaglianone E, Di Rosa R, Fiocca F, Basoli A. Plastic biliary stent occlusion: factors involved and possible preventive approaches. Clin Med Res 2007; 5 (01) 53-60
• 9 Kumar S, Chandra A, Kulkarni R, Maurya AP, Gupta V. Forgotten biliary stents: ignorance is not bliss. Surg Endosc 2018; 32 (01) 191-195
• 10 Döbrönte Z, Patai A. Fokozott mütéti kockázatú betegek nagy epeúti köveinek palliatív kezelése endoscopos endoprothesis implantatióval. [Palliative treatment of large bile duct stones by endoscopic implantation of endoprosthesis in high risk patients] Orv Hetil 1996; 137 (09) 461-464
• 11 Leung JW, Ling TK, Kung JL, Vallance-Owen J. The role of bacteria in the blockage of biliary stents. Gastrointest Endosc 1988; 34 (01) 19-22
• 12 De Palma GD, Galloro G, Siciliano S, Magno L, Catanzano C. Risultati dell'utilizzo di protesi per via endoscopica nel trattamento della litiasi difficile della via biliare principale. [Results of the use of endoprostheses in the treatment of retained common bile duct stones] Minerva Chir 2000; 55 (12) 823-827
• 13 Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 2006; 63 (07) 986-995
• 14 Walter D, van Boeckel PG, Groenen MJ. et al. Cost efficacy of metal stents for palliation of extrahepatic bile duct obstruction in a randomized controlled trial. Gastroenterology 2015; 149 (01) 130-138
• 15 Pisello F, Geraci G, Li Volsi F, Modica G, Sciumè C. Permanent stenting in “unextractable” common bile duct stones in high risk patients. A prospective randomized study comparing two different stents. Langenbecks Arch Surg 2008; 393 (06) 857-863
• 16 Bergman JJ, Rauws EA, Tijssen JG, Tytgat GN, Huibregtse K. Biliary endoprostheses in elderly patients with endoscopically irretrievable common bile duct stones: report on 117 patients. Gastrointest Endosc 1995; 42 (03) 195-201
• 17 Lawrence C, Romagnuolo J, Payne KM, Hawes RH, Cotton PB. Low symptomatic premature stent occlusion of multiple plastic stents for benign biliary strictures: comparing standard and prolonged stent change intervals. Gastrointest Endosc 2010; 72 (03) 558-563
• 18 Moesch C, Sautereau D, Cessot F. et al. Physicochemical and bacteriological analysis of the contents of occluded biliary endoprostheses. Hepatology 1991; 14 (06) 1142-1146
• 19 Kaneko J, Kawata K, Watanabe S. et al. Clinical characteristics and risk factors for stent-stone complex formation following biliary plastic stent placement in patients with common bile duct stones. J Hepatobiliary Pancreat Sci 2018; 25 (10) 448-454 Lexicon grading Kaneko
• 20 Freitas M, Lima Capela T, Macedo Silva V. et al. Real-life patency of plastic biliary stents in the pandemic era: is stent removal after 6 months safe and effective?. Scand J Gastroenterol 2023; 58 (07) 798-804